Mark Bear wins Society for Neuroscience Julius Axelrod Prize
Award recognizes professor's synaptic plasticity research, its translation to potential amblyopia and autism treatments, and his career of mentorship.
Award recognizes professor's synaptic plasticity research, its translation to potential amblyopia and autism treatments, and his career of mentorship.
Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease.
Professor Li-Huei Tsai studies how brain waves can be used to treat neurodegenerative diseases such as Alzheimer’s.
MIT CSAIL researchers combine AI and electron microscopy to expedite detailed brain network mapping, aiming to enhance connectomics research and clinical pathology.
BRAIN CONNECTS supports McGovern Institute and Department of Brain and Cognitive Sciences research aimed at mapping the brain’s connections.
Images that humans perceive as completely unrelated can be classified as the same by computational models.
Professor Mark Bear's research on brain plasticity spins off a promising candidate to treat amblyopia, or lazy eye.
Scientists have invested decades in piecing together how our vision is so good at recognizing what’s familiar. A new study overcomes an apparent discrepancy in data to reveal a new insight into how it works.
Study finds that in worms, the HSN neuron uses multiple chemicals and connections to orchestrate egg-laying and locomotion over the course of several minutes.
Through his leadership and vision, McGovern Institute postdoc Ubadah Sabbagh aims to improve the scientific process in the US and abroad.
Neurons stochastically generated up to eight different versions of a protein-regulating neurotransmitter release, which could vary how they communicate with other cells.
Department of Brain and Cognitive Sciences faculty members Ev Fedorenko, Ted Gibson, and Roger Levy believe they can answer a fundamental question: What is the purpose of language?
In a simple game that humans typically ace, mice learn the winning strategy, too, but refuse to commit to it, new research shows.
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
Howard Hughes Medical Institute Gilliam Fellows are selected for their promise as future leaders in their scientific fields and for their commitment to advancing equity and inclusion.